CardioFocus HeartLight Post-Approval Study
Sponsored by CardioFocus
About this study
This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.
This is a prospective, open-label, multi-center, single arm study designed to assess continued safety and effectiveness of the HeartLight System during commercial use in participants being treated for drug refractory, symptomatic, paroxysmal atrial fibrillation.
Where this study is enrolling (3)
- I'm interested
University of Arizona Sarver HeartCenter
Tucson, Arizona
- I'm interested
Mount Sinai Hospital
New York, New York
- I'm interested
University Of Virginia Health System
Charlottesville, Virginia
Who can participate
Inclusion criteria
- ✓18 years or older
- ✓planned for catheter ablation due to symptomatic paroxysmal atrial fibrillation
- ✓failure of at least one anti-arrhythmic drug
- ✓others
Exclusion criteria
- ✕overall good health as established by multiple criteria
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.